Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VK3-OCH3 (2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na) is a selective antitumor agent via heme oxygenase (HO-1) related mechanisms; Vitamine K3 analogue.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 93.00 | |
2 mg | In stock | $ 148.00 | |
5 mg | In stock | $ 212.00 | |
10 mg | In stock | $ 297.00 | |
25 mg | In stock | $ 547.00 | |
50 mg | In stock | $ 788.00 | |
100 mg | In stock | $ 1,080.00 |
Description | VK3-OCH3 (2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na) is a selective antitumor agent via heme oxygenase (HO-1) related mechanisms; Vitamine K3 analogue. |
Synonyms | 2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na |
Molecular Weight | 262.32 |
Formula | C14H14O3S |
CAS No. | 255906-59-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25mg/mL(95.3 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VK3-OCH3 255906-59-3 Others HO-1 inhibit apoptosis IMR-32 cell G2/M phase VK-3-OCH3 2-[(2-Methoxy)ethylthio]-3-methyl-1,4-na VK3OCH3 Caveolin-1 Inhibitor VK3 OCH3 cytotoxicit inhibitor